Skip to content

Drug interactions

Bosentan + Nirmatrelvir

Severity: Major

Bosentan and Nirmatrelvir: major interaction.

Last updated Sources: US FDA label

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Nirmatrelvir is given with ritonavir, which strongly inhibits CYP3A4 and raises bosentan concentrations. This can cause hepatotoxicity, hypotension and fluid retention.

What this interaction means in plain words

Bosentan and Nirmatrelvir can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Bosentan belongs to Miscellaneous; Nirmatrelvir belongs to Anti Virals.

Evidence level: Moderate

Why it happens

Ritonavir-boosted nirmatrelvir inhibits CYP3A4 and hepatic uptake of bosentan, increasing its exposure.

What to do

Stop bosentan at least 36 hours before starting nirmatrelvir/ritonavir and resume it about 10 days after starting. Monitor for hypotension and liver toxicity.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bosentan and Nirmatrelvir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Bosentan with Nirmatrelvir?

MediHelp rates the interaction as major. Bosentan and Nirmatrelvir can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Nirmatrelvir is given with ritonavir, which strongly inhibits CYP3A4 and raises bosentan concentrations. This can cause hepatotoxicity, hypotension and fluid retention.

How serious is the interaction between Bosentan and Nirmatrelvir?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Stop bosentan at least 36 hours before starting nirmatrelvir/ritonavir and resume it about 10 days after starting. Monitor for hypotension and liver toxicity.

What other medicines interact with Bosentan?

MediHelp also lists interactions of Bosentan with, for example, Cyclosporin, Glibenclamide, Glyburide-metformin. The full list is on the Bosentan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in